Almirall SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Moody's assigns first time Ba3 CFR to Almirall SA; outlook stable
Almirall SA:Moody's Investors Service has assigned Ba3 corporate family rating (CFR) and Ba3-PD probability of default rating (PDR) to Almirall.Moody's has assigned (P)Ba3 rating to proposed 325 million euro senior unsecured notes maturing in 2021.Outlook on ratings is stable.This is first time Moody's has assigned rating to company.
Latest Developments for Almirall SA
- Almirall gets authorization from European Commission to sell drug combination of aclidinium and formoterol in EU
- AstraZeneca PLC announces strategic respiratory transaction with Almirall SA
- Almirall completes senior notes pricing; reveals credit rating by S&P
- Almirall SA announces proposal not to pay dividends
Latest Key Developments in Pharmaceuticals
- Share this
- Digg this